预防性葡萄糖凝胶不能预防新生儿低血糖:一项准实验先导研究
该准实验研究纳入236例有低血糖风险的无症状新生儿,预防组(72例)在首次喂养后颊黏膜涂抹0.5 mL/kg葡萄糖凝胶,对照组(164例)仅喂养。首次血糖浓度两组无差异(52.1±17.1 vs 50.5±15.3 mg/dL,P=.69),NICU入住率分别为9.7%和14.6%(P=.40)。结论为预防性葡萄糖凝胶未减少新生儿短暂性低血糖或NICU入住。
要点
- 预防性葡萄糖凝胶未提高首次喂养后血糖浓度。
- 预防性葡萄糖凝胶未降低因低血糖的NICU入住率。
- Insta-Glucose碳水化合物浓度77%可能引起高胰岛素反应。
核心结论
- 预防性葡萄糖凝胶未能减少新生儿短暂性低血糖或NICU入住。
研究设计与样本
- 准实验先导研究,将无症状高危新生儿分配至预防性葡萄糖凝胶组或其他高危婴儿作为对照组,共236例(预防组72例,对照组164例)。
主要发现
- 首次血糖浓度在预防组与对照组间双变量分析无差异(52.1±17.1 vs 50.5±15.3 mg/dL,P=.69),校正协变量后仍无差异(P=.18)。
- 因治疗短暂性新生儿低血糖的NICU入住率分别为9.7%和14.6%(P=.40)。
关键数值与推荐
- 预防组在首次喂养后接受0.5 mL/kg葡萄糖凝胶(Insta-Glucose)颊黏膜涂抹,30分钟后检测血糖。
临床怎么用
- 对于有低血糖风险的无症状新生儿,预防性使用葡萄糖凝胶未显示获益,不应常规用于预防低血糖或减少NICU入住。
局限性
- 研究为准实验设计,非随机分组,样本量较小(共236例),可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the hypothesis that prophylactic dextrose gel administered to newborn infants at risk for hypoglycemia will increase the initial blood glucose concentration after the first feeding and decrease neonatal intensive care unit (NICU) admissions for treatment of asymptomatic neonatal hypoglycemia compared with feedings alone. STUDY DESIGN: This quasi-experimental study allocated asymptomatic at-risk newborn infants (late preterm, birth weight <2500 or >4000 g, and infants of mothers with diabetes) to receive prophylactic dextrose gel (Insta-Glucose; Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey); other at-risk infants formed the control group. After the initial feeding, the prophylactic group received dextrose gel (0.5 mL/kg) rubbed into the buccal mucosa. The blood glucose concentration was checked 30 minutes later. Initial glucose concentrations and rate of NICU admissions were compared between the prophylactic group and controls using bivariate analyses. A multivariable linear regression compared first glucose concentrations between groups, adjusting for at-risk categories and age at first glucose concentration. RESULTS: There were 236 subjects (72 prophylactic, 164 controls). The first glucose concentration was not different between the prophylactic and control groups in bivariate analysis (52.1 ± 17.1 vs 50.5 ± 15.3 mg/dL, P = .69) and after adjusting for covariates (P = .18). Rates of NICU admission for treatment of transient neonatal hypoglycemia were 9.7% and 14.6%, respectively (P = .40). CONCLUSIONS: Prophylactic dextrose gel did not reduce transient neonatal hypoglycemia or NICU admissions for hypoglycemia. The carbohydrate concentration of Insta-Glucose (77%) may have caused a hyperinsulinemic response, or alternatively, exogenous enteral dextrose influences glucose homeostasis minimally during the first few hours when counter-regulatory mechanisms are especially active. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02523222.
引用
- Coors SM, Cousin JJ, Hagan JL, et al. Prophylactic Dextrose Gel Does Not Prevent Neonatal Hypoglycemia: A Quasi-Experimental Pilot Study. J Pediatr. 2018. PMID: 29605395. doi:10.1016/j.jpeds.2018.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。